Semaglutide Canada
Updated May 2026

Semaglutide in Canada

Independent pricing, provider comparisons, and clinical research for Canadians considering Ozempic, Wegovy, or the newly launched generic semaglutide. No affiliations. No sponsored rankings.

Couple cooking together in a kitchen — Canadian semaglutide and GLP-1 medication guide
Coverage Canada-Focused
Updated: May 2026

What You Need to Know in 2026

Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes) and Wegovy (approved for weight management). It works by mimicking the GLP-1 hormone, which slows gastric emptying, reduces appetite, and helps regulate blood sugar. In the landmark STEP 1 trial, participants lost an average of 14.9% of their body weight over 68 weeks.

The biggest shift this year is that generic semaglutide is now available in Canada. After Novo Nordisk's data exclusivity expired on January 4, 2026, Health Canada authorized Dr. Reddy's on April 28, 2026 and Apotex on May 1, 2026. Both generic versions reached Canadian pharmacies in May 2026 at an early street price of roughly $100–$150 CAD per month. Additional applications from Sandoz, Teva Canada and other manufacturers remain under Health Canada review, which is expected to push prices down further as more competitors launch through the rest of 2026.

Brand-name Ozempic still costs $250–$310 per month and Wegovy runs $540–$570 per month without insurance. Provincial coverage is limited for weight management (most plans require Special Authority for diabetes only), but private insurance through employers often covers it. Telehealth platforms like Felix Health and Maple have made the prescription process faster than the traditional clinic route, and several have already added the new generics to their formularies.

Who Writes This

Written by medical researchers. Reviewed by a Canadian pharmacist.

Every article is researched and written by our independent editorial team, then fact-checked against Health Canada filings, peer-reviewed studies, and Canadian provincial formularies, with articles reviewed by a Canadian-licensed pharmacist.

Canadian Telehealth Providers

Platforms where Canadian patients can consult a physician and get semaglutide prescribed online. Prices reflect medication cost, not consultation fees.

MyRocky

⭐ Top Pick
Ozempic / month $300–$310 CAD
Coverage All 10 provinces
Includes $99 consult + labs
Read Our Review

Felix Health

Generic Waitlist
Ozempic / month $250–$310 CAD
Coverage All provinces (excl. QC)
Read Our Review

Maple

Ozempic / month $253–$310 CAD
Coverage Nationwide (24/7)
Read Our Review

Hims Canada

Generic Waitlist
Ozempic / month TBA
Coverage ON, BC, AB (expanding)
Read Our Review

Track every new generic semaglutide launch in Canada

Generic semaglutide is now available from Dr. Reddy's and Apotex. We'll email you as each new manufacturer (Sandoz, Teva and others) ships, pharmacy pricing drops, and provincial coverage changes.

Frequently Asked Questions

Yes. Health Canada approved Wegovy (semaglutide 2.4 mg) for chronic weight management in adults with a BMI of 30+, or 27+ with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Ozempic is approved for type 2 diabetes but is frequently prescribed off-label for weight loss.
Yes. Semaglutide is prescription-only in Canada. You need a licensed physician or nurse practitioner to evaluate your medical history and write a prescription. This can be done through your family doctor, a walk-in clinic, or an accredited telehealth platform like Felix Health or Maple.
Brand-name Ozempic costs roughly $250–$310 CAD per month without insurance. Wegovy runs $540–$570 CAD per month. Generic semaglutide injection launched in Canadian pharmacies in May 2026 (Dr. Reddy's and Apotex) at an estimated $100–$150 CAD per month, and prices are expected to drop further as Sandoz, Teva Canada and other applicants are approved.
Coverage varies by province. Most provincial formularies (OHIP, BC PharmaCare, Alberta Blue Cross) list Ozempic for type 2 diabetes with Special Authority approval, but coverage for weight management alone is limited. Private group insurance plans through employers often provide broader coverage. British Columbia recently added limited semaglutide coverage for weight management under specific criteria.
Yes — generic semaglutide injection launched in Canadian pharmacies in May 2026. Health Canada authorized Dr. Reddy's Laboratories on April 28, 2026 and Apotex on May 1, 2026, with both products now reaching pharmacies nationwide. Additional applications from Sandoz, Teva Canada and other manufacturers remain under Health Canada review, which is expected to push prices down further as more competitors enter the market through the rest of 2026.
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These are typically mild to moderate and tend to decrease over the first 8–12 weeks as the dosage is gradually titrated upward. Serious but rare side effects include pancreatitis and gallbladder problems. Your prescribing physician will review your full risk profile before starting treatment.